Products
Latest News
FAQ
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma
Phase 1
Completed
Conditions
Asthma
Interventions
Drug: ABT-308
Drug: Placebo
Subscribe
First Posted Date
2009-09-29
Last Posted Date
2017-11-21
Lead Sponsor
AbbVie
Target Recruit Count
47
Registration Number
NCT00986037
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy